These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9693760)

  • 1. [Interaction of C-reactive protein with alpha-chain of interleukin-2 receptor].
    Nazarov PG
    Biull Eksp Biol Med; 1998 Jun; 125(6):657-60. PubMed ID: 9693760
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of melatonin on lymphocyte proliferation and production of interleukin-2 (IL-2) and interleukin-1 beta (IL-1 beta) in mice splenocytes].
    Arias J; Melean E; Valero N; Pons H; Chacín-Bonilla L; Larreal Y; Bonilla E
    Invest Clin; 2003 Mar; 44(1):41-50. PubMed ID: 12703182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action.
    Colic M; Vucevic D; Vasilijic S; Popovic L; Pejanovic V; Jandric D; Medic-Mijacevic L; Rakic L
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):583-90. PubMed ID: 10669901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctions in lymphocyte responses to IL-2 and IL-15 reflect differential ligand binding interactions with the IL-2Rbeta chain and suggest differential roles for the IL-2Ralpha and IL-15Ralpha subunits.
    de Jong JL; Farner NL; Sondel PM
    Cytokine; 1998 Dec; 10(12):920-30. PubMed ID: 10049515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
    Hank JA; Surfus JE; Gan J; Jaeger P; Gillies SD; Reisfeld RA; Sondel PM
    Clin Cancer Res; 1996 Dec; 2(12):1951-9. PubMed ID: 9816154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of high-affinity IL-2-IL-2R interaction for T cell anergy induction.
    Hayashi RJ; Kanagawa O
    Int Immunol; 2006 May; 18(5):645-51. PubMed ID: 16574670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling.
    Conrad DM; Hanniman EA; Watson CL; Mader JS; Hoskin DW
    J Cell Biochem; 2004 May; 92(2):387-99. PubMed ID: 15108363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compensatory energetic mechanisms mediating the assembly of signaling complexes between interleukin-2 and its alpha, beta, and gamma(c) receptors.
    Rickert M; Boulanger MJ; Goriatcheva N; Garcia KC
    J Mol Biol; 2004 Jun; 339(5):1115-28. PubMed ID: 15178252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The murine anti-human common gamma chain monoclonal antibody CP.B8 blocks the second step in the formation of the intermediate affinity IL-2 receptor.
    Baker DP; Whitty A; Zafari MR; Olson DL; Hession CA; Miatkowski K; Avedissian LS; Foley SF; McKay ML; Benjamin CD; Burkly LC
    Biochemistry; 1998 Oct; 37(41):14337-49. PubMed ID: 9772159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
    Viehl CT; Moore TT; Liyanage UK; Frey DM; Ehlers JP; Eberlein TJ; Goedegebuure PS; Linehan DC
    Ann Surg Oncol; 2006 Sep; 13(9):1252-8. PubMed ID: 16952047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 induction of ACTH secretion: presence of an interleukin-2 receptor alpha-chain-like molecule on pituitary cells.
    Smith LR; Brown SL; Blalock JE
    J Neuroimmunol; 1989 Feb; 21(2-3):249-54. PubMed ID: 2536395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo staphylococcal enterotoxin B (SEB)-primed murine splenocytes secrete mediators which suppress CD25(hi) expression and cell cycle progression of naive splenocytes in response to SEB in vitro.
    Hsu LJ; Jan MS; Lin YS
    Cell Immunol; 2000 Apr; 201(1):50-7. PubMed ID: 10805973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology. An antibody paradox, resolved.
    Prlic M; Bevan MJ
    Science; 2006 Mar; 311(5769):1875-6. PubMed ID: 16574856
    [No Abstract]   [Full Text] [Related]  

  • 15. Homogeneous time-resolved IL-2-IL-2R alpha assay using fluorescence resonance energy transfer.
    Stenroos K; Hurskainen P; Eriksson S; Hemmilä I; Blomberg K; Lindqvist C
    Cytokine; 1998 Jul; 10(7):495-9. PubMed ID: 9702412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective stimulation of T cell subsets with antibody-cytokine immune complexes.
    Boyman O; Kovar M; Rubinstein MP; Surh CD; Sprent J
    Science; 2006 Mar; 311(5769):1924-7. PubMed ID: 16484453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of interleukin-2 receptor in mitogenic action of C-reactive protein on lymphocytes].
    Nazarov PG; Polevshchikov AV
    Vestn Ross Akad Med Nauk; 1993; (9):13-7. PubMed ID: 7510175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 blocks the antitumour activity caused by depletion of CD25 cells in a murine renal adenocarcinoma model.
    Takeuchi T; Konno-Takahashi N; Kasuya Y; Ogushi T; Nishimatsu H; Kitamura T
    BJU Int; 2004 Jul; 94(1):171-6. PubMed ID: 15217455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
    Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
    Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
    Yasuda T; Bundo K; Hino A; Honda K; Inoue A; Shirakata M; Osawa M; Tamura T; Nariuchi H; Oda H; Yamamoto T; Yamanashi Y
    Int Immunol; 2007 Apr; 19(4):487-95. PubMed ID: 17329234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.